Other treatment options for patients with enzyme or protein deficiencies include substrate reduction therapy, gene therapy, and bone-marrow derived stem cell transplantation.

History

ERT was developed in 1964 by Christian de Duve and Roscoe Brady. Leading work was done on this subject at the